Donation Programs:
Novartis
About Novartis
Novartis was created in 1996 from the merger of two
Swiss-based pharmaceutical companies, Sandoz and Ciba. At the time,
the creation of Novartis was the largest corporate merger in history.
Headquartered in Basel, Switzerland, and operating in over 140
countries around the world, Novartis currently employs about 74,000
worldwide. From its development, manufacture, distribution and sales
of pharmaceutical and consumer health products, Novartis has sales
of $19.1 billion in 2001 with net income of about $4.2 billion.
Corporate Giving
The concept of corporate social responsibility is featured prominently
on the company's website and includes a link to the Corporate
Citizenship at Novartis report. The report clearly sets
out the corporate philosophy and policy about Novartis' corporate
accountability.
The website also include a paper presented by Dr. Klaus M. Leisinger,
Director of the Novartis
Foundation for Sustainable Development, presented in Berlin
on October 1, 2002. Entitled "The Pharmaceutical Industry and
Social Responsibility: Idealism without Illusion and Realism Without
Resignation", this paper presents the challenges and issues
facing the pharmaceutical industry in defining their roles in global
health disparities. This article can be found here.
Many other articles addressing issues of business development, social
responsibility and related issues are at the Foundation website
at www.novartisfoundation.com.
International Essential Medicine Donation Programs
Novartis supports international essential donation programs by
providing direct disaster relief and by working in private-public
partnership with other organizations as well as through the Novartis
Foundation for Sustainable Development.
According to the Novartis website:
Novartis provides disaster relief aid on a case-by-case basis.
To ensure that the aid reaches those who need it, Novartis transfers
it to reliable international organizations or through Novartis
subsidiaries in the country concerned. When aid is provided in
the form of products, Novartis specialists oversee their proper
use.
In addition to the disaster relief work, Novartis participates
in the fight against malaria by supplying the company's malaria
combination drug at cost to the World Health Organization for use
in developing countries.
Novartis is involved in the push to eliminate leprosy. The company
produces two drugs that are highly effective in treating and curing
this disease and is working with the Global
Alliance for Leprosy Elimination by supplying its drugs for
free to the World Health Organization. Along with the Novartis Foundation,
the company is working to improve access to diagnosis and medication,
treatment and rehabilitation.
The company is working with the government of Brazil to eradicate
leprosy and ensure access to medicine and treatment in that country
that has about 78,000 leprosy cases. More information about this
program is available at www.novartis.com/corporatecitizen/en/unglobalcompact/leprosy.shtml.
Please visit the Novartis website at www.novartis.com
to learn more about the company and its private-public partnerships
to improve global health.
<< Return
to Donation Programs Main Page
|
